We are live on ! Find out more
PETX

Aratana Therapeutics, Inc.
PETX

Delisted

PETX was delisted on the 17th of July, 2019.

13 hedge funds and large institutions have $37.8M invested in Aratana Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+13
Holders Change %
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PETX Hedge Fund Activity: Q2 2013 in Review

13 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q2 2013, worth a combined $37.8M.

Buyers outnumbered sellers: 13 funds opened new PETX positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.

  • 13 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $37.8M of Aratana Therapeutics, Inc. stock for Q2 2013.
  • 13 funds opened new Aratana Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +13 holders.

Based on aggregated 13F filings for Q2 2013.